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Using video-annotation software to identify
interactions in group therapies for
schizophrenia: assessing reliability and
associations with outcomes
Stavros Orfanos1* , Syeda Ferhana Akther1, Muhammad Abdul-Basit1, Rosemarie McCabe2 and Stefan Priebe1
Abstract
Background: Research has shown that interactions in group therapies for people with schizophrenia are associated
with a reduction in negative symptoms. However, it is unclear which specific interactions in groups are linked with
these improvements. The aims of this exploratory study were to i) develop and test the reliability of using video-
annotation software to measure interactions in group therapies in schizophrenia and ii) explore the relationship
between interactions in group therapies for schizophrenia with clinically relevant changes in negative symptoms.
Methods: Video-annotation software was used to annotate interactions from participants selected across nine
video-recorded out-patient therapy groups (N = 81). Using the Individual Group Member Interpersonal Process Scale,
interactions were coded from participants who demonstrated either a clinically significant improvement (N = 9) or no
change (N = 8) in negative symptoms at the end of therapy. Interactions were measured from the first and last sessions
of attendance (>25 h of therapy). Inter-rater reliability between two independent raters was measured. Binary logistic
regression analysis was used to explore the association between the frequency of interactive behaviors and changes in
negative symptoms, assessed using the Positive and Negative Syndrome Scale.
Results: Of the 1275 statements that were annotated using ELAN, 1191 (93%) had sufficient audio and visual quality to
be coded using the Individual Group Member Interpersonal Process Scale. Rater-agreement was high across all interaction
categories (>95% average agreement). A higher frequency of self-initiated statements measured in the first session was
associated with improvements in negative symptoms. The frequency of questions and giving advice measured in the first
session of attendance was associated with improvements in negative symptoms; although this was only a trend.
Conclusion: Video-annotation software can be used to reliably identify interactive behaviors in groups for schizophrenia.
The results suggest that proactive communicative gestures, as assessed by the video-analysis, predict outcomes. Future
research should use this novel method in larger and clinically different samples to explore which aspects of therapy
facilitate such proactive communication early on in therapy.
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Background
Negative symptoms of schizophrenia are categorized along
two dimensions: a reduction in expression, including lack
of speech (alogia) and reduced facial expression (blunt
affect); and a deficit in experiencing motivation (asociality)
and pleasure (anhedonia) [1, 2]. A meta-analysis [3] found
that psychological interventions delivered in groups im-
prove these symptoms compared to treatment as usual. It
was therefore concluded that interactions in a group for-
mat are clinically advantageous in the treatment of nega-
tive symptoms of schizophrenia and should be explored
further [3]. If specifically helpful or unhelpful group inter-
actions can be identified, which are linked to changes in
negative symptoms, these interactions can be encouraged,
or discouraged, to improve the optimal effectiveness of
group therapies.
Little research has sought to investigate interactions
on a moment-to-moment basis in group therapies for
schizophrenia; an approach referred to as ‘interactional
analysis’ (IA) [4]. In a study by Kanas and colleagues [5],
the Hill Interaction Matrix [6] was used to code group
interactions from verbally spoken statements. In doing
so, they identified beneficial interactions fostered within
the group as expression of emotions, reality testing and
advice giving. However, there are at least three methodo-
logical limitations with this study. First, measurement
reliability was not tested, as ratings were limited to a
single researcher. Second, no attempt was made to
statistically explore the relationship between interactions
and clinical outcomes. Third, ratings were made in real-
time through a one-way mirror, and therefore a more fine-
grained analysis of group interactions was not possible.
Beck and Lewis [4] argue that the accuracy and practi-
cality of IA can be improved by new video technologies.
Research on psychiatrist-patient communication [7, 8]
highlights the benefit of using video-annotation software
such as ELAN [9]. This free software can be used flex-
ibly to annotate digitally recorded data from small, inex-
pensive and commercially available 2D video recording
devices. Crucially, annotations in ELAN can be made
with a precision of up to 50 frames per second. Hence it
is feasible to assume that using ELAN, verbal interac-
tions can be accurately annotated and rated in the con-
text of subtle nonverbal cues associated with clinical
outcomes in schizophrenia [10–13].
There were two aims of this study. First was to de-
velop and test the reliability of combining IA and ELAN
video-annotation software to measure interactions in a
group therapy for schizophrenia. In doing so, we sought
to combine ELAN with the Individual Group Member
Interpersonal Process Scale (IGMIPS) [14–16]. The
second aim of this study was to assess the link between
group interactions and changes in negative symptoms.
This aspect of the study was exploratory. Hence
interactions were compared across participants with
either a clinically relevant improvement or no change in
negative symptoms, and there were no fixed predictions
about which IGMIPS categories would predict outcomes.
Readily available video recordings of diagnostically
homogenous group therapies for individuals with schizo-
phrenia were used in this study. These included Body-
Oriented Psychotherapy (BPT) groups and Cognitive
Behavioral Therapy (CBT) groups. BPT is a manualized
intervention broadly aimed at reducing negative symp-
toms by refocusing cognitive and emotional awareness
towards the body to stimulate activity [17, 18]. CBT is
also a manual intervention, broadly aimed at addressing
negative symptoms through thoughts, demoralized feel-
ings and behaviors that lead to social isolation and social
apathy [19]. The high audio and visual quality of the
digitally recorded data was expected to contribute to
high inter-rater agreement of the ratings between two
independent raters.
Methods
This study used video recordings and pre-post symptom
measurements from a pool of 81 participants who
attended nine separate group therapies for schizophre-
nia. Data from participants attending eight of the nine
groups were collected as part of the NESS Trial. The
NESS trial is a multi-centred randomized controlled trial
(RCT) that examined the effectiveness of BPT for nega-
tive symptoms of schizophrenia in comparison to an ac-
tive control group (trial registration ISRCTN84216587).
Data from participants attending one of the nine groups
was collected from a CBT group for this study. The BPT
groups consisted of 20 sessions over 10 weeks and the
CBT was 14 sessions over 10 weeks. All sessions lasted
90 min. Further details of BPT and CBT treatment
groups are outlined elsewhere [17–20].
Sample
Participants were recruited from out-patient mental
health services between 2012 and 2014. Participants
were aged between 18 and 65 years, had a diagnosis of
schizophrenia, scored 18 or above on the negative
subscale of the Positive and Negative Syndrome Scale
(PANSS) [21], were willing to participate and were able
to provide written informed consent.
Interactions were assessed from participants with clin-
ically relevant changes in negative symptoms, i.e. those
who met the criteria of being an ‘improver’, and partici-
pants who met the criteria for being a ‘no-changer’.
Improvers were participants who had a clinically signifi-
cant reduction on the PANSS negative symptoms
subscale from the baseline to end of treatment assess-
ment phase, defined as a clinically relevant reduction of
at least 20% [22]. No-changers were participants who
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had either no change in the PANSS negative symptoms
subscale, a reduction of just one point from baseline to
end of treatment assessment phase, or an improvement
of just one point from baseline to end of treatment
assessment phase.
Participants were excluded if they had an insufficient
command of English, a physical disability that impaired
participation in groups, did not attend at least one session
within the first and last five sessions of the group, and did
not meet the criteria of an ‘improver’ or ‘no-changer’.
Participants who did not have a 20% negative symptom
reduction in the Clinical Assessment Interview for Nega-
tive Symptoms (CAINS) [2], a more specific measure of
negative symptoms, were also excluded from the ‘im-
prover’ category. Participants who demonstrated a reduc-
tion of more than 10% in negative symptoms measured by
the CAINS were excluded from the ‘no changer’ category.
Outcome measures
Positive and negative symptom scale [21]
The PANSS is a semi-structured interview, consisting of
30-items designed to measure positive, negative and gen-
eral symptoms of schizophrenia. The PANSS negative
symptom subscale was used for the primary outcome
‘improver status’ - a binary outcome, which indicated
whether the participants were improvers or no-changers.
The negative symptom subscale includes seven items
related to a difficulty in abstract thinking, poor rapport,
emotional withdrawal, passive social withdrawal, lack of
speech, stereotyped thinking and blunt affect.
Individual group member interpersonal process scale [14]
The IGMIPS [14] provides a structured coding format
from which interactive behaviors made by individual
group members are rated. ‘Frequency ratings’, indicating
the presence of each interactive behavioral category,
were assessed as the main primary independent variable
of interest. A summary of the IGMIPS categories is out-
lined in Table 1. Frequency ratings for each category
were measured as a binary outcome (yes or no). ‘Signifi-
cance ratings’, rated on a Likert-scale, were also made to
determine the intensity of a given interactive behavior.
Furthermore, ‘where ratings’ were described in accord-
ance to the ‘locational focus’ of a statement, along with
‘who’ statements referring to whom and/or what the
statement is made about.
Procedure
Negative symptoms were measured before and after
treatment. Baseline assessments were made within
4 weeks of the BPT and CBT groups starting and end-
of-treatment assessments were made within 4 weeks of
the BPT and CBT groups finishing. Six independent
research assistants who had no involvement in the
treatment conducted assessments. The trial through
which the BPT groups were set up was a double-blind
RCT. Hence, the researchers who collected this data
were blind to treatment allocation, clinical outcomes
and group attendance. Assessments for participants
attending the CBT group were made by an unblinded
researcher (SO). Hence a portion of these assessments
were video-recorded and re-assessed by an independent
blinded assessor. It was found that there was high inter-
rater reliability (>0.82) between the two assessors before
beginning the analysis of group interactions.
The analysis of group interactions occurred in two
stages. In stage one, ‘individual statements’ were tran-
scribed from participants who were identified as im-
provers and no-changers. These verbal statements were
the primary source of material from which interactions
were measured. Single ‘statements’ were defined as an
utterance of three or more words, bound either by a
pause of more than 10 s or by an interruption by
another group member. All statements were transcribed
from the video-recorded group sessions using ELAN
annotation software [9]. Two video-recordings, from
opposite angles in the group therapy room, were used
when transcribing individual statements (see Fig. 1).
Both video-recordings included their own audio file,
which were used interchangeably in ELAN depending
on the audio quality at each angle.
In the second stage of analysis, the group interactions
were judged from the transcribed statements, using the
structured coding format outlined in the IGMIPS. An
adapted version of the original IGMIPS-III manual was
developed for this study by the first author (SO) - see
Additional file 1: Table S1 for a detailed outline of this
adapted manual. Using the video-recordings of the
sessions, statements were rated in the context of nonver-
bal cues such as tone, gaze and hand gestures. Individual
statements were rated in accordance to whom the state-
ment was being made to (i.e. self, therapist, group as a
whole or other group member), the locational focus of
the statement (i.e. life outside the group vs. inside the
group) and whether the statement was self-initiated or
elicited.
All interactions were first coded by SO. Thirty percent
of statements were then rated by an independent re-
searcher (SA), who received 3 days of training. The
statements rated by SA were chosen at random and were
stratified by participant. During this period a sufficient
inter-rater reliability (over 80% rater agreement) was
achieved.
Statistical analysis
All analyses were conducted in STATA/SE version 12.0
(StatCorp. 2011), where p < 0.05 was taken to indicate
statistical significance and p < 0.10 was taken to indicate
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a statistical trend. Frequency ratings, indicating the pres-
ence of interactive behaviors, were calculated as sample
population percentage scores for each improver and no-
changer. The sample population percentage was calcu-
lated by dividing the total number of statements rated
‘yes’ (i.e. present) for each IGMIPS category, by the
total number of statements made by each participant.
Scores were calculated for statements made in the
first and last sessions of attendance, each of which
were 90 min long.
Rater agreement between SO and SA was calculated to
ensure sufficient coding reliability: this was calculated as
the percentage of categories coded by both SO and SA
as ‘present’. An alternative statistical test of inter-rater
reliability that can account for any rater agreement that
occurs due to chance, such as Cohen’s Kappa, was con-
sidered. However, the type of data measured within the
IGMIPS categories varied across the different IGMIPS
categories; including binary outcome data (yes/no for
the ‘frequency of interactive behavior’ ratings), con-
tinuous outcome data (for the ‘significance’ ratings)
and nominal outcome data (for the ‘who’ ratings).
Therefore no statistical test of inter-rater reliability
that could account for this variation was deemed suit-
able. Furthermore, the actual percentage agreement
was deemed as more informative than a statistical test
of inter-rater reliability, which relies on the preva-
lence of the measure (i.e. the number of statements
rated per person).
The relationship between the frequency of interactive
behavior and improver-status was explored through a
series of binary logistic regression analyses. Separate ana-
lyses were conducted for each category outlined in the
IGMIPS. Furthermore, separate analyses were conducted
Table 1 Summary of the interactive behavioral categories outlined in the Individual Group Member Interpersonal Process Scale
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for statements coded from the first and last sessions.
Significance ratings were adjusted for.
Results
Sample characteristics
Of the 81 participants recruited to the nine therapy
groups included in this study, 17 participants met the
inclusion criteria. Nine participants met the criteria for
‘improvers’ and eight participants met the criteria for
‘no-changers’. The characteristics of these participants
are outlined in Table 2.
In total, 1275 individual statements were coded in
accordance with the categories outlined in the IGMIPS.
Eighty-four of these statements (7%) were excluded from
the analysis as they were rated as ‘less than 50% audible’
- i.e. less than 50% of the statement could be annotated
due to inaudibility of the statement. The frequency of
interactive behaviors are summarized in Table 3.
Inter-rater reliability
Across all IGMIPS categories, there was 96% agreement
between the two independent ratings made by SO and
SA. There was 92% agreement for all frequency categor-
ies rated either ‘yes’ or ‘no’. In addition, there was 98, 99
and 95% agreement for significance, locational and who
items respectively. See Table 4 for a summary of the
percentage agreement for each of the categories.
Linking frequency ratings of interactive behaviors and
improver-status
Findings from the binary logistic regression analyses,
which explored the relationship between the frequency of
interactive behaviors and improver-status, are summarized
in Table 5.
There was a significant association between self-
initiated statements and improver-status in the first
session of attendance (95% CI = 1.00 to 1.13, p < 0.05);
where a higher frequency of self-initiated statements in
the first session of attendance was associated with being
an ‘improver’ at the end of treatment. For statements
occurring in the last session of attendance, there was a
statistical trend between the frequency of self-initiated
statements and improver-status (OR = 1.08, 95% CI = 0.99
to 1.18, p = 0.083). There was also a trend for an associ-
ation between the frequency of questions (95% CI = 1.00
Fig. 1 Example screenshot of video-annotation in ELAN
Table 2 Participant characteristics and number of statements made in the first and last sessions of attendance
Improver-status % Male Average Age Average Change in
Negative Symptoms
Statements Deleted (%) Individual Statements Analyzed (N)
First session of attendance Last session of attendance All
Improvers 75 42.2 0.25 10 189 185 374
No-changers 89 41.7 −5.80 9.8 291 526 817
First = number of statements made in first session, Last = number of statements made in the last session, All = number of statements across both first and
last sessions
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to 1.14, p = 0.067) and improver-status, and giving advice
(95% CI = 1.00 to 2.07, p = 0.067) and improver-status;
where a higher frequency of statements involving ques-
tions or giving advice in the first session of attendance
was associated with being an ‘improver’ at the end of
treatment.
There was no statistically significant evidence for a rela-
tionship between these variables in the last session of at-
tendance. There was no statistically significant evidence for
any of the other IGMIPS categories and improver status.
Discussion
Summary of findings
In line with our first hypothesis, the overall agreement
between the two researchers was high. This supports the
feasibility of combining a group behavioral coding scale,
such as the IGMIPS, with ELAN video-annotation soft-
ware. There was minimal disagreement between raters
on coding the IGMIPS categories, further supporting its
feasibility in measuring a range of individual group
member interactions.
There was also evidence that group interactions,
measured on a moment-to-moment basis using video-
annotation software, were predictive of negative symptom
outcomes. A higher frequency of self-initiated statements
in the first session of attendance was associated with a
clinically significant improvement in negative symptoms
following participation in group therapy. There was also
evidence for a statistical trend between more questions
and advice giving in the first session of attendance, and
improved odds of clinical improvements in negative
symptoms.
Strengths and limitations
This study had a number of strengths. First, stringent
measures were taken to ensure that observer-rated
Table 3 Percentages of individual statements indicating the presence of IGMIPS interaction categories and corresponding
significance ratings
IGMIPS
Category
IMPROVERS NO-CHANGERS
First session Last session First session Last session
Self 64.9 (19.1) 74.0 (9.47) 78.2 (14.7) 74.2 (16.2)
Others 8.30 (6.47) 9.04 (7.55) 8.71 (9.23) 12.6 (14.9)
Therapist 26.4 (18.65) 21.7 (14.8) 14.7 (15.6) 12.6 (12.9)
Impersonal Abstract 23.2 (23.1) 17.2 (14.7) 11.6 (13.9) 13.3 (9.61)
Humor 14.6 (7.84) 18.2 (18.7) 12.3 (10.8) 21.8 (19.1)
Self-initiated 55.0 (15.6) 46.7 (9.38) 25.0 (28.70 30.2 (20.6)
Personal Information 19.1 (13.2) 26.3 (17.9) 19.5 (13.2) 28.0 (19.0)
Significance rating 2.39 (0.92) 2.01 (0.39) 2.49 (0.90) 2.17 (0.83)
Positive 32.3 (13.7) 44.7 (9.66) 32.7 (19.2) 55.4 (17.1)
Significance 2.39 (0.69) 2.43 (0.35) 2.84 (0.77) 2.47 (0.54)
Negative 16.0 (12.3) 12.5 (13.0) 14.7 (13.2) 20.4 (17.4)
Significance rating 1.69 (0.66) 1.71 (0.35) 1.62 (0.87) 1.70 (0.51)
Connected 4.54 (5.37) 8.17 (9.99) 6.47 (6.66) 10.2 (7.04)
Disconnected 0.53 (1.59) 0.96 (1.63) 0.00 3.70 (6.93)
Self-aware 16.6 (10.3) 22.9 (13.3) 14.6 (12.37) 26.4 (19.9)
Significance rating 1.39 (0.32) 1.45 (0.23) 1.23 (0.33) 1.24 (0.19)
Unaware 3.24 (5.12) 2.77 (3.27) 2.84 (4.25) 2.20 (4.25)
Significance rating 1.05 (0.10) 1.08 (0.14) 1.00 (0.00) 1.25 (0.35)
Sensitivity 5.03 (5.77) 2.32 (3.79) 1.39 (2.58) 1.81 (3.37)
Significance rating 1.30 (0.67) 1.24 (0.19) 1.25 (0.35) 1.38 (0.18)
Insensitivity 1.89 (3.19) 2.36 (3.40) 3.14 (6.55) 2.02 (5.70)
Significance rating 1.00 (0.00) 1.00 (0.00) 1.00 (0.00) 1.1 (N/A)
Asked questions 28.3 (19.0) 20.5 (14.1) 10.8 (14.4) 12.8 (17.4)
Enhanced awareness 2.35 (3.15) 5.60 (8.08) 0.00 1.34 (2.50)
Significance rating 1.5 (1.00) 1.30 (0.45) N/A 1.00 (0.00)
Gave advice 8.94 (8.52) 6.87 (8.29) 1.22 (2.28) 3.28 (6.05)
Orfanos et al. BMC Psychiatry  (2017) 17:65 Page 6 of 10
group interactions were measured reliably, with minimal
rater-bias. Participant statements were transcribed by two
trained researchers to ensure minimal errors in annotating
individual statements. Interactions were measured from
group sessions that were recorded in high-definition with
two microphone sources, for optimal visual and audio
quality. Furthermore, coding reliability was assessed from
a randomly selected proportion of statements coded by an
independent researcher. Second, assessments of negative
symptoms on 15 of the 17 participants were conducted by
blinded researchers as part of a randomized controlled
trial. Third, interactions were measured across multiple
group psychological therapies, which have varying thera-
peutic orientations. Fourth, the impact of group interac-
tions was explored in participants with clinically relevant
outcomes, selected from a large pool of participants who
attended multiple groups for schizophrenia.
One limitation is multiple testing. Given that separate
logistic regression analyses were conducted for each of
the IGMIPS categories, the chances of finding a false
positive were high. A further limitation was the small
sample included in the logistic regression analyses. This
meant that these analyses lacked the power to detect a
significant change in the odds of being an improver or
no-changer following group attendance. Hence it is not
possible to conclude with confidence that an effect of
the frequency of interactions on improver status did not
exist where there was no statistical evidence for an ef-
fect. Despite careful planning, there was also inevitably a
degree of opportunism, such that data included in this
study depended on the availability and quality of data
that could be obtained from the NESS trial. Further-
more, the generalizability of the findings is arguably
questionable, since eight of the nine groups from which
data were collected were BPT groups. Given that therap-
ist behavior wasn’t rated, it is not known how the thera-
peutic orientation of the intervention affected group
interactions.
Interpretation of findings
The results from this study suggest that modern video-
recording devices and ELAN video-annotation software
can be used to identify moment-to-moment group inter-
actions [4]. Researchers can improve the feasibility of
this approach by focusing their resources on the inter-
active categories identified as being most important in
this study. Annotating the verbally spoken statements
from the video-recorded sessions was notably the most
time-consuming process. To date, clinical research has
focused on advancing technologies that automatically an-
notate nonverbal interactive behaviors, for example 3D
motion detection [23] or motion energy analysis [24].
Until recently, these approaches have only been possible
to use in laboratory or restricted spaces, and therefore lack
ecological validity. We therefore propose that future re-
search would benefit more from exploring whether auto-
matic voice recognition and transcription technologies
[25] can be used with the approach described in this study.
Table 4 Inter-rater percentage agreement scores for each
IGMIPS category between two independent raters
IGMIPS
Rating Categories
Percentage Agreement
Discusses Self 91
Discusses Others 92
Discusses Therapist 92
Discusses Abstract Issues 92
Who 83
Humor 93
Self-initiated 86
Personal Information 88
Significance 94
Where 96
Positive Sentiment 88
Who 93
Significance 96
Negative Sentiment 87
Who 99
Significance 99
Connected 93
Who 94
Disconnection 94
Who 94
Self awareness 92
Where 98
Significance 99
Self-unawareness 98
Where 100
Significance 100
Interpersonal Sensitivity 98
Significance 100
Interpersonal Insensitivity 96
Significance 100
Question 96
Where 96
Enhance OGM awareness 97
Where 100
Significance 100
Gives advice 96
Where 100
A score of ‘100’ for participant 1 in the ‘self’ category means that there was
100% agreement between the two independent raters for statements rated
as ‘self’
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In particular, whether prosodic features of speech shown
to be linked to negative symptoms of schizophrenia [26]
can be used to improve the accuracy and feasibility of
assessing important group interactions. Nonetheless, the
research conditions, in particular the video recording
equipment, did not appear to impact the clinical integrity
of the treatment. Whilst this supports the feasibility of
using this approach in common clinical practice, future
research is needed to test the potential ease of transfer-
ability of the method described.
The results from this study support the hypothesis that
interactions between group members in group therapies
are linked to improvements in negative symptoms [3].
Negative symptoms are difficult to treat with conven-
tional psychological and pharmacological medications
and are linked with poor quality of life and impaired
social functioning [27–29]. Hence our findings, which
give insight into what type of group interactions are
linked to clinically relevant improvements in this symp-
tom domain, have important clinical implications. For
example, clinicians may want to consider emphasizing
activities aimed at promoting interactions related to
initiating statements, asking questions or giving advice
in group therapies.
The finding that self-initiation, advice giving and ques-
tion asking are associated with improvements in nega-
tive symptoms is in line with research within the field of
conversational analysis in schizophrenia. Within this lit-
erature, studies have found that ‘proactive’ communica-
tive behaviors are associated with outcomes [7, 8, 23].
For example, in doctor-patient consultations, proactive
gestures and asking questions have been linked with
improved clinical decision making and treatment adher-
ence [7]. Based on this literature and the results from
this study, future research should explore the clinical
impact of actively enhancing these types of interactions
in the treatment of schizophrenia.
The method described may also be useful in identify-
ing beneficial group interactions from the very first
session of therapy. In accordance with research on group
therapeutic processes [30, 31], individualized psycho-
therapy [32] and pharmacological treatment [33], the
findings from this study highlight the importance of an
initial positive response to therapy. Future research
should therefore explore the impact of promoting bene-
ficial group interactions from the very first session. In
doing so, baseline participant characteristics shown to
be related to clinical outcomes in schizophrenia, for
example cognitive performance [34], should also be
measured and accounted for.
Conclusions
This study highlights the reliability of using video-
annotation software to assess moment-to-moment
Table 5 Summary of logistic regressions exploring the relationship between the frequency of interactive behaviors and improver-status
IGMIPS Category First session Last session
Odds Ratio SE P value 95% CI Odds Ratio SE P value 95% CI
Discusses self 0.95 0.03 0.131 0.88, 1.06 1.00 0.04 0.980 0.92, 1.10
Discusses others 0.99 0.07 0.910 0.87, 1.13 0.97 0.04 0.515 0.89, 1.06
Discusses therapist 1.04 0.03 0.181 0.98, 1.11 1.05 0.04 0.196 0.97, 1.14
Discusses impersonal/abstract 1.04 0.03 0.244 0.97, 1.10 1.03 0.04 0.519 0.94, 1.12
Uses humor 1.03 0.06 0.591 0.92, 1.15 0.99 0.03 0.678 0.94, 1.04
Self-initiated 1.06 0.03 0.046 1.00, 1.13 1.08 0.05 0.083 0.99, 1.18
Personal Information 0.98 0.05 0.643 0.88, 1.08 0.99 0.03 0.693 0.93, 1.05
Positive sentiment 0.95 0.05 0.265 0.86, 1.04 0.93 0.04 0.147 0.85, 1.02
Negative sentiment 1.01 0.04 0.862 0.93, 1.09 0.92 0.05 0.101 0.82, 1.02
Demonstrates connection 0.94 0.08 0.493 0.79, 1.12 0.97 0.06 0.624 0.86, 1.09
Demonstrates disconnection N/Aa 0.84 0.16 0.350 0.58, 1.22
Demonstrates self-awareness 0.97 0.06 0.625 0.87, 1.09 0.95 0.04 0.211 0.87, 1.03
Demonstrates un-awareness 1.07 0.18 0.679 0.77, 1.48 0.77 0.21 0.336 0.45, 1.32
Demonstrates sensitivity to others 1.34 0.42 0.361 0.72, 2.50 0.79 0.50 0.496 0.40, 1.57
Demonstrates insensitivity to others 0.98 0.13 0.891 0.76, 1.27 0.01 2.58 0.996 0
Asks question 1.06 0.04 0.067 1.00, 1.14 1.04 0.04 0.310 0.97, 1.11
Enhances awareness to others N/Aa 1.10 0.17 0.523 0.81, 1.50
Gives advice 1.42 0.27 0.067 1.00, 2.07 1.08 0.09 0.323 0.92, 1.27
aN/A – no statements made by participants in the no-changer category were rated as ‘disconnection’ or ‘enhanced awareness’ in the first session, therefore logistic
regressions were not possible for these IGMIPS categories. SE standard error, CI confidence interval
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interactions in a naturalistic group therapy setting for
schizophrenia. Moreover, the findings suggest that
behaviors assessed by this novel method are relevant
for outcomes in therapies for patients with negative
symptoms of schizophrenia. In particular, proactive com-
munication identifiable from the very initial session, in-
cluding self-initiated (rather than elicited) statements,
advice giving and asking questions, appeared to be linked
with clinically significant improvements at the end of
treatment. Clinicians may therefore want to consider
emphasizing activities aimed at promoting interactions re-
lated to proactive communication. Future research should
explore what aspects of therapy facilitate such proactive
communication early on in therapy.
Additional file
Additional file 1: Table S1. IGMIPS Rating Adapted Manual.
(DOCX 136 kb)
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